Texas Bocheng Pharmaceutical

Dezhou Bocheng Pharmaceutical Technology Co., Ltd., frequently translated as Texas Bocheng Pharmaceutical, is a pharmaceutical company based in Dezhou, Shandong Province, China. The company was established following the restructuring of the state-owned Shandong Dezhou Pharmaceutical Factory and has a significant history in the production of chemical drugs and active pharmaceutical ingredients (APIs). Its commercial portfolio includes a range of essential medicines, most notably the chemotherapy drug Cisplatin, the antihypertensive agent Nifedipine, and the antibiotic Viomycin. Dezhou Bocheng operates manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards, with capabilities in small molecule synthesis and the production of freeze-dried powder injections. The company serves both the domestic Chinese healthcare market and international partners, focusing on therapeutic areas such as oncology, cardiovascular health, and infectious diseases.